Veeva OpenData and Network Transform Boehringer Ingelheim's Customer Engagement Strategy

In a groundbreaking announcement made by Veeva Systems (NYSE: VEEV) on July 23, 2025, Boehringer Ingelheim has become the latest addition to the list of top 20 companies in the biopharma sector that have standardized their customer data across more than 100 countries using Veeva OpenData and Veeva Network.

The integration of Veeva's OpenData solutions equips Boehringer Ingelheim's teams with precise and comprehensive customer reference data. This empowers them to provide relevant information to healthcare professionals (HCPs), while also laying the groundwork for advancements in artificial intelligence (AI) within the company. Uday Bose, the Head of Global Customer Experience Excellence and Business Steering at Boehringer Ingelheim, emphasized that expanding their partnership with Veeva through globally harmonized data will strengthen customer engagement and set the stage for future AI applications.

The implementation of Veeva OpenData and Veeva Network will offer a unified view of customers to both field and brand teams at Boehringer Ingelheim, enabling them to engage in impactful and coordinated interactions with a focus on improving patient outcomes. By consolidating their data strategy into a comprehensive solution, Boehringer Ingelheim is simplifying data management and enhancing overall operational efficiency.

The standardization process ensures quick access to consistent and high-quality customer data across different teams and regions, fostering improved teamwork and collaboration. The interconnected software and data provided by Veeva further facilitate Boehringer Ingelheim's migration to Veeva Vault CRM by leveraging native OpenData and network integrations.

Kilian Weiss, Senior Vice President of Data Cloud International at Veeva, remarked that Boehringer Ingelheim's forward-looking strategy leveraging connected software and data systems is fundamental for maintaining commercial excellence and achieving future success in AI. The integration of Vault CRM, OpenData, and Network presents a cohesive solution that unifies data, enhances doctor engagement, and promotes widespread innovations in AI.

Veeva OpenData is a pivotal component of the Veeva Data Cloud, which also includes Veeva Link, Veeva Compass, and Veeva CRM Pulse. Meanwhile, Veeva Network is integrated into the Vault CRM Suite, which connects sales, marketing, and medical teams for seamless collaboration and more effective business processes.

As the leading provider of cloud software for the life sciences industry, Veeva is committed to innovation, product quality, and customer success, serving over 1,000 customers ranging from large biopharmaceutical firms to emerging biotech companies. As a Public Benefit Corporation, Veeva strives to align the interests of all stakeholders, including customers, employees, shareholders, and the industries it engages with. For more information, visit veeva.com/eu.

Conclusion

Veeva OpenData and Network not only represent a significant technological advancement for Boehringer Ingelheim but also signal a transformative shift in how biopharma companies can utilize data to drive better outcomes and foster innovation in the healthcare sector. Looking ahead, the move places Boehringer Ingelheim in a prime position to leverage data-driven insights and AI technologies, helping to navigate the complexities of patient care and engagement effectively.